These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 7672761)

  • 21. [Postoperative evaluation of esophageal mucosal change dynamics in patients with reflux diseases].
    Wallner G; Misiuna P; Chibowski D; Polkowski W; Abramowicz K; Sory A
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():273-81. PubMed ID: 9446369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Haber M
    Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between endoscopic esophagitis and patterns of gastroesophageal reflux in ambulatory pHmetry.
    Sánchez-Gey Venegas S; Yerro Páez VM; Pellicer Bautista FJ; Fuerte Seda M; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 1999 Feb; 91(2):125-32. PubMed ID: 10231304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
    Córdova-Villalobos JA; Ramírez-Barba EJ; Ramírez-Covarrubias JC
    Rev Gastroenterol Mex; 1996; 61(4):306-9. PubMed ID: 9072780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy and prevention of reflux esophagitis. Results of a multicenter study with cimetidine. I: Epidemiology and results of acute therapy].
    Siewert JR; Ottenjann R; Heilmann K; Neiss A; Döpfer H
    Z Gastroenterol; 1986 Aug; 24(8):381-95. PubMed ID: 3532592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Our experience in the treatment of reflux esophagitis with histamine H2 receptor antagonists].
    Cappelli J; Morobe J; Van Laethem A; Musin L
    Acta Chir Belg; 1983; 83(6):440-3. PubMed ID: 6318487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The microwave resonance therapy of reflux esophagitis].
    Nikula TD; Moĭseenko VA
    Vrach Delo; 1990 Oct; (10):97-9. PubMed ID: 2080599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reflux esophagitis and the principles of its diagnosis].
    Utkin VV; Ambalov GA; Apinis BK
    Sov Med; 1980; (3):94-7. PubMed ID: 7376022
    [No Abstract]   [Full Text] [Related]  

  • 31. Pseudomembranous esophagitis.
    Nayyar AK; Royston C; Slater DN; Bardhan KD
    Gastrointest Endosc; 2001 Dec; 54(6):730-5. PubMed ID: 11726849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics of the clinical course, diagnosis and treatment of reflux esophagitis in pregnancy].
    Burkov SG
    Akush Ginekol (Mosk); 1990 Nov; (11):36-8. PubMed ID: 2077910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of H2-blocker-resistant reflux esophagitis in severely handicapped children with omeprazole].
    Maeoka Y; Eda I
    No To Hattatsu; 1996 Jan; 28(1):74-7. PubMed ID: 8579863
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of sinusoidal modulated currents and mud applications in reflux esophagitis].
    Dzvonkovskaia VV
    Vrach Delo; 1987 Jun; (6):34-6. PubMed ID: 3498262
    [No Abstract]   [Full Text] [Related]  

  • 35. [Peptic esophagitis in the neonate. A case-report (author's transl)].
    Kubryk N; Borde M
    Ann Pediatr (Paris); 1982 May; 29(5):361-4. PubMed ID: 7201771
    [No Abstract]   [Full Text] [Related]  

  • 36. A solution to the reflux problem?
    Vogten AJ
    Neth J Med; 1985; 28(5):180-1. PubMed ID: 4010834
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic efficacy revisited.
    Graham DY
    Dig Dis Sci; 1984 Jun; 29(6):589-90. PubMed ID: 6723487
    [No Abstract]   [Full Text] [Related]  

  • 38. Short and long-term outcome of medically treated reflux esophagitis.
    Pace F; Sangaletti O; Trapé E; Santalucia F; Bianchi Porro GB
    Hepatogastroenterology; 1995 Apr; 42(2):131-4. PubMed ID: 7672761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.
    Ladas SD; Tassios PS; Raptis SA
    Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
    Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.